EGCGs therapeutic window varies based on target condition and patient factors, with high doses potentially leading to adverse effects like hepatotoxicity
Keeping the area clean and dry, avoiding shaving directly over the wound, and protecting the site from direct sun exposure all support clean healing
Improves Skin Tone Regular therapy helps lighten and even out skin tone, addressing discoloration and promoting a youthful glow
Other allicin-derived compounds, including diallyl sulfides, ajoenes, and vinyldithiins, have not been detected in human blood, urine, or stool, even after the consumption of up to 25 g of fresh garlic or 60 mg of pure allicin (5)
Market Size and Forecast Market Size in 2025: USD 60.6 Billion Market Size by 2035: USD 307 Billion CAGR: 17.61% from 2026 to 2035 Base Year: 2025 Forecast Period: 2026-2035 Historical Data: 2022-2024 To Get more information on GLP-1 Receptor Agonist Market - Request Free Sample Report GLP-1 Receptor Agonist Market Trends Oral GLP-1 formulations led by Novo Nordisk's Rybelsus and Eli Lilly's orforglipron in development are expanding the patient population who will accept GLP-1 therapy by removing the injection barrier that constrains current market penetration
